Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

Mon, 02nd Nov 2020 20:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Sensyne Health PLC - clinical artificial intelligence company - Notes its CVm-Health+a software application is being used to facilitate the rapid Covid-19 antigen testing study by the University of Oxford. The FACTS study is one of the three university pilot projects established by the UK Department for Health & Social Care and Public Health England. Sensyne's app will be used to provide access to study information and links to training materials and will record health status and test result data for students and staff.

----------

Lamprell PLC - United Arab Emirates based oil rig construction business - Wins "medium-sized" contract from International Maritime Industries to undertake engineering design services. IMI is a joint venture between Saudi Aramco, Lamprell, Bahri and Hyundai Heavy Industries. Lamprell defines a "medium-sized contract" as between USD6 million and USD50 million. The work will start immediately and is expected to take three years, with an initial phase incorporating full detailed design engineering, followed by the production design phase.

----------

Restore PLC - AIM-listed support services company - Acquires E Recycling Ltd, a high security IT asset destruction business for an undisclosed fee. "Euro Recycling is a profitable business and is expected to generate revenues of approximately GBP2.5 million per annum. By bringing Euro Recycling into the group's market leading ITAD platform, the board sees significant opportunity to accelerate growth," Restore said.

----------

San Leon Energy PLC - independent oil and gas exploration company - Notes further three-week extension over its proposed investment in Decklar Petroleum Ltd and the Oza field in Nigeria. The extension has been moved to November 21. The extension is to finalise certain conditions precedent in the subscription agreement, which have taken longer to conclude due to travel restrictions in place as a response to Covid-19, San Leon said.

----------

Synairgen PLC - Southampton University spin-off working in drug discovery and biotechnology - Raises GBP7 million through open offer, giving the firm total proceeds of GBP87 million from its recent placing. Will admit 34.8 million new shares, with 30.8 million from its placing and 4.0 million via the open offer.

----------

Gresham House PLC - UK-based specialist alternative asset manager - Sells 50 megawatt battery storage project to London-listed Gresham House Energy Storage Fund PLC. The project located near Thurcroft, to the east of Rotherham was sold for a total enterprise value of approximately GBP32.5 million, plus up to GBP750,000 of deferred contingent consideration. The investment in the project is consistent with exceeding Gresham House's 15% return on balance sheet capital threshold over the medium term. After this sale, Gresham House has an exposure of GBP3.6 million in the remaining battery storage development projects it has funded, which are in exclusivity with Gresham House Energy Storage Fund.

----------

Creo Medical Group PLC - medical device company - Receives 510(k) clearance from the US Food & Drug Administration for its tissue ablation device MicroBlate Fine. Creo notes the is the third device to gain FDA regulatory clearance within Creo's portfolio of flexible endoscopy devices for the gastrointestinal market. MicroBlate tissue ablation technology utilises Creo's very high frequency microwave energy allowing physicians to precisely ablate diseased tissue in multiple organ types and many different clinical access methods, Creo says. "With regulatory clearance in the UK and Europe and US clearances coming through, we are gearing up for first clinical use of these products in various markets. This rapid progression of device clearances, along with the recent dramatic expansion of Creo's Global commercial sales capability, puts Creo in great shape to drive global commercialisation," Chief Executive Craig Gulliford added.

----------

Kromek Group PLC - supplier of radiation detection components and devices - Enters into a development agreement, worth up to USD660,000, with an unnamed US-based industrial OEM with a global customer base, according to Kromek. The majority of the development programme is scheduled to be delivered during the Kromek's current financial year and, following final completion, it is expected to transition to a multi-year supply contract. For the deal, Kromek will customise one of its CZT detector platforms for incorporation into the customer's systems for identifying contaminations during production processes.

----------

Sabien Technology Group PLC - AIM-listed energy efficiency technology firm - Confirms negotiations are still ongoing with Ptarmigan Health Destinations SA over a potential acquisition deal. Says further details will be announced in due course.

----------

Mode Global Holdings PLC - banking, payments, investment, and loyalty programme digitalisation firm - Completes the buy-out of the 45% minority interest in its payments operating subsidiary - JGOO Ltd, which operates as part of Mode for Business - from Pure NZ Gateway Ltd. The transaction price was not disclosed. The transaction includes the purchase of JGOO's technology and the rights associated to it. "Buying out Pure NZ Gateway consolidates Mode's business and value proposition," Mode said.

----------

Watchstone Group PLC - insurance, technology and healthcare firm - Completes sale of Ingenie business. As a result, is now a cash shell and has until May 1 to complete an acquisition or reverse takeover. Alternatively, can re-admit shares to AIM as an investment company, but will need to raise at least GBP6 million for that to happen.

----------

Curzon Energy PLC - investor in US based natural gas projects - Remains in discussions with Sun Seven Stars Investment Group over a potential extension of the exclusivity period with a view to a transaction, the terms of which have yet to be agreed. "While the parties continue to work constructively towards renewing exclusivity and a potential transaction, there can be no certainty around the length of time required to reach definitive agreement or the likelihood of concluding a successful transaction," Curzon adds.

----------

K3 Business Technology Group PLC - Enterprise software company - Says trading in the second half of the financial year ending November 30 was in line with the second quarter and management expectations. K3 says its own IP and Global Accounts businesses showed "particular resilience". Also noted its second half is typically stronger. "October is an important month for annual software licence and maintenance contract renewals, and these have progressed well with renewal rates tracking at normal high levels," K3 added. Continues to focus on expanding own IP sales, particularly the K3-imagine platform.

----------

Seneca Global Income & Growth PLC - trust hoping to combine the benefits of a quarterly income with long term capital growth - Renews GBP10 million revolving credit facility with The Royal Bank of Scotland International Ltd, London Branch for a further two years. The facility bears interest at 1.05% over LIBOR and may be used for the acquisition of investments in accordance with the company's investment policy and for the funding of share buy backs and dividend payments.

----------

ADES International Holding PLC - drilling oil and gas wells company - Secures a new two-year early production facility contract in Egypt. Under the agreement, ADES will establish an early production deck floor and top side facilities in addition to a jack-up barge charter. Also notes it has successfully extended the contract for Rig 40 in Saudi Arabia for an additional three months to the end of the first quarter of 2021.

----------

Adriatic Metals PLC - precious and base metals explorer and developer - Completes binding subscription agreement with the European Bank for Reconstruction & Development, where the bank to subscribe for 5.3 million shares at GBP1.175 per share. Adriatic closed at 118.00 pence in London on Monday.

----------

Coro Energy PLC - South East Asian energy company focused on transition to a low carbon economy - Acquires 20% shareholding in ion Ventures Holdings Ltd, a South East Asian and UK focused developer of clean energy projects, including renewables and battery storage for cash consideration of GBP500,000. Alongside this initial investment, the company has been granted a priority right of first refusal to invest in each of ion Venture's South East Asian projects prior to financial close. Coro says the deal gives it immediate access to the existing ion Ventures pipeline of approximately 20 high quality clean energy projects.

----------

Ascent Resources PLC - independent oil and gas exploration company with a focus on European onshore projects - Further to the announcements of 14 and 30 April 2020, it has agreed a six month extension to the Memorandum of Understanding which it has signed with Cupet, the Cuban national oil company. The MoU gives Ascent the exclusive right to negotiate the production sharing contracts for the onshore producing Block 9B and onshore exploration Blocks 9A, 12 and 15.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Sep 2014 11:03

Synairgen Swings To Profit On Transformational AstraZeneca Deal

Read more
4 Jul 2014 12:11

Synairgen raises funds to develop AstraZeneca drug

Synairgen has placed 12.2m shares to raise funds for the assessment and preparation of SNG001, the drug recently licensed from AstraZeneca, across five projects that it has identified as the most suitable direction for its development. The drugs company raised around £5.3m before expenses after is

Read more
4 Jul 2014 07:21

UK MORNING BRIEFING: William Hill Promotes From Within

Read more
4 Jul 2014 06:47

Synairgen Raises GBP5.3 Million In Share Placing At 50 Pence

Read more
15 Jun 2014 12:28

Sunday share tips: Whitbread, Petra Diamonds, Empiric Student Property

Whitbread looks like a reliable investment despite the imminent departure of Chairman Anthony Habgood, Matthew Goodman said in the Sunday Times's Inside the City column. The company was a mess when Habgood took over in 2005 but he has sold peripheral businesses to focus on Premier Inn and Costa Coff

Read more
12 Jun 2014 16:37

MARKET COMMENT: FTSE 100 Closes Slightly Higher Amid Iraqi Tensions

LONDON (Alliance News) - The FTSE 100 closed fractionally higher Thursday, having spent the day trading within a tight range, with oil and gas exploration and production company BG Group leading the gains as the price of oil climbed amid escalating violence in Iraq.

Read more

12 Jun 2014 10:23

TOP NEWS: Discount Retailer B&M Prices Biggest London IPO Of 2014

LONDON (Alliance News) - The following is a summary of top news stories Thursday.
----------
COMPANIES
----------
The initial public offering of B&M European Value Retail SA, the discount retailer chaired by former TescoRead more

12 Jun 2014 08:25

London open: Mining stocks pull FTSE 100 lower ahead of data

- Profit taking continues as miners fall - Traders await global economic data - Broker downgrades hit blue chips techMARK 2,839.63 -0.04% FTSE 100 6,827.09 -0.17% FTSE 250 16,073.58 -0.09% UK stocks opened flat on Thursday morning as weakness in the mining sector held back any chances of a rebound

Read more
12 Jun 2014 07:42

AstraZeneca signs licence deal with Synairgen

British drugs maker AstraZeneca has signed a licence agreement with AIM-listed Synairgen for the development of SNG000l, a treatment for respiratory tract viral infections in patients with severe asthma. Under the deal, FTSE 100-listed Astra will pay Synairgen a $7.25m up-front fee and potential de

Read more
12 Jun 2014 07:36

UK MORNING BRIEFING: AstraZeneca Signs Asthma Deal With Synairgen

LONDON (Alliance News) - UK shares have opened flat Thursday, following negative trading in the US and Asia overnight.

AstraZeneca is the third biggest gainer on the FTSE 100. The drugmaker said it has signed a global licence agreement with AIM-listed biotechnology

Read more
12 Jun 2014 06:52

AstraZeneca Licences Asthma Exacerbation Treatment From Synairgen

LONDON (Alliance News) - AstraZeneca PLC said Thursday that it had signed a global licence agreement with AIM-listed biotechnology company Synairgen PLC for its SNG001 compound for the treatment of infections that exacerbate asthma. The compound is used to treat respiratory tract infections

Read more
20 Mar 2014 12:47

Synairgen Pretax Loss Narrows On Expenses

LONDON (Alliance News) - Synairgen PLC Thursday said its pretax loss narrowed in its full year 2013 as administrative expenses fell during the period. The respiratory drug discovery and development company said its pretax profit narrowed to GBP2.3 million from GBP2.5 million the previous ye

Read more
5 Mar 2014 11:31

Synairgen Jumps As It Raises Cash While Progressing Licensing Talks

LONDON (Alliance News) - Synairgen PLC Wednesday said it has raised GBP1.5 million by placing 3.1 million shares at 48 pence each, money it will use for working capital while it progresses current licensing discussions through to a conclusion. In a statement, the respiratory drug discovery

Read more
5 Mar 2014 08:31

UK MORNING BRIEFING: Standard Chartered Profits Fall, Cuts Bonus Pool

LONDON (Alliance News) - Shares have opened mostly lower Wednesday with small-caps out-performing large caps, following Tuesday's relief rally from lowered Ukraine tensions.

Standard Chartered has reported lower 2013 profit and a 15% reduction in its bonus pool, whi

Read more
5 Dec 2012 11:10

Synairgen reports 'significant progress'

Synairgen, a respiratory drug discovery and development company, has reported 'significant progress' since the end of June. The firm said that discussions with potential licensing partners for its SNG001 product have progressed, the company has engaged with the US government to investigate the pote

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account